Reagent kit for detecting 2-diabetes serum mark in Chinese people
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- THE INST OF BASIC MEDICAL SCI OF CHINESE ACAD OF MEDICAL SCI
- Publication Date
- 2007-03-14
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The present invention relates to a serum marker of type 2 diabetes. The serum marker is Galectin-1, that is, soluble galactosidase-binding lectin protein type 1 (lectin, galactoside-binding, soluble, 1). The present invention also relates to a detection kit designed using the identified marker galectin-1 and its expression level changes in patients. Further, the present invention also relates to the role of the serum marker in the diagnosis of diabetes, and as a target for drug design for diabetes treatment. Background technique
[0002] As we all know, type 2 diabetes is a complex trait disease controlled by multiple genes, with obvious genetic predisposition. At present, it is believed that related protein molecules involved in insulin signal transduction pathway, glucose transport pathway, glycogen synthesis pathway, fatty acid absorption and synthesis, and adipocyte differentiation pathway may be related to the occurrence of diabetes. Research on...